康复医疗训练 人形机器人何时有用武之地？

Core Viewpoint - Fourier, a humanoid robot company, is focusing on the healthcare sector as a key area for its embodied intelligence strategy, leveraging its background in rehabilitation robotics [1][3]. Group 1: Company Strategy - Fourier has launched two models of its GR series humanoid robots in 2023 and 2024, marking its 10th anniversary and signaling a shift towards healthcare applications [3]. - The founder and CEO, Gu Jie, emphasized that the company has extensive experience in product development through collaboration with medical teams and patients, making healthcare a natural fit for its technology [5]. - Fourier's rehabilitation robots are already deployed in over 3,000 hospitals globally, showcasing its established presence in the healthcare market [5]. Group 2: Market Demand and Challenges - The healthcare sector has a significant demand for embodied intelligence robots, particularly due to uneven distribution of healthcare resources and varying levels of professional care in different regions [8]. - Gu Jie highlighted that robots can standardize treatment quality and training intensity, addressing disparities in human therapists' methods and effectiveness [8]. - The successful implementation of embodied intelligence robots in healthcare hinges on two critical factors: efficacy in clinical outcomes and safety in medical-grade quality [8]. Group 3: Industry Outlook - The adoption of embodied intelligence technology in healthcare is more challenging than in other industries due to a lack of interdisciplinary talent and high regulatory barriers [9]. - Medical institutions are currently cautious, preferring to observe the development of humanoid rehabilitation devices before fully committing to their use [9]. - Gu Jie anticipates that it will take approximately three to four years for these robots to transition from prototype to clinically viable products, including the time needed for regulatory approvals [9].